{
  "docId": "019de074-2973-7208-9395-338d3116556a",
  "docSlug": "4059563425860536cb0bf09c6eb6bba5",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 29 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 29,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "before_after",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a split-layout with a summary of the partnership on the left and a timeline of expansion on the right.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-2973-7208-9395-338d3116556a/25",
  "deckHref": "/decks/019de074-2973-7208-9395-338d3116556a",
  "deckJsonHref": "/decks/019de074-2973-7208-9395-338d3116556a.json",
  "deckAnchorHref": "/decks/019de074-2973-7208-9395-338d3116556a#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.65,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "2019: Initial deal focussed on Chronic Kidney Disease & Idiopathic Pulmonary Fibrosis; 2022: 3-year collaboration expansion to include Heart Failure & Systemic lupus erythematosus",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9756fa3-1313-46e3-93fe-41193560ef4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.75,
        "y": 0.05
      },
      "kind": "image",
      "text": "AstraZeneca",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "975eb655-6702-46d6-9e70-f0af4ba30b58",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.5,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "list",
      "text": "Separate data environment established to integrate AstraZeneca’s data into a bespoke Knowledge Graph; BenevolentAI and AstraZeneca teams working in close collaboration to explore, identify and validate targets; Deal structure of upfront license fee, milestone payments and downstream royalties; Data generated via the collaboration enriches the Benevolent Platform™",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5bb128cd-2c24-4d7e-b655-7ea7499d3dac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.65,
        "y": 0.15
      },
      "kind": "metric",
      "text": "Five novel targets selected for AstraZeneca’s portfolio to date",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7180823-cf2f-44dc-9986-82cbe247cd6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Multi-year Target-ID collaboration is delivering multiple, novel targets for complex diseases with high unmet need",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e25e2890-0d8c-4c3b-a66d-0662e031f9d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Strategic validation: successful collaboration with AstraZeneca",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f197f485-ed1e-48b8-a2b4-2fd364aac670",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "684f2785-da38-4fac-ac34-62956320b0ef",
      "evidence": "The right side of the slide displays a chronological progression of the partnership from 2019 to 2022.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 29,
      "from": 16,
      "beatId": "3b0e5288-2029-43c9-ada8-d64afac944d7",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "The call to action is clear, with a roadmap and ask for investors",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 25,
      "from": 25,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "13a3b42f-d473-4dba-85f1-49ecd5f863e1",
      "evidence": "The presentation highlights a successful collaboration with AstraZeneca",
      "position": 1,
      "objective": "Show the value of collaboration",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.6,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}